Publications

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

AuthID
P-00Z-DQE

Author(s)

Khan, MS

Anker, SD

Filippatos, G

Ferreira, JP

Pocock, SJ

Januzzi, JL

Chopra, VK

Piña, IL

Böhm, M

Ponikowski, P

Verma, S

Brueckmann, M

Vedin, O

Peil, B

Zannad, F

Packer, M

Butler, J

Document Type

Article

Year published

2023

Published

in JOURNAL OF CARDIAC FAILURE, ISSN: 1071-9164

Volume: 29, Issue: 10, Pages: 1345-1354 (10)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.cardfail.2023.06.024

Pubmed: 37558088

Wos: WOS:001103175200001

Source Identifiers

ISSN: 1071-9164

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the Emperor-Reduced Trial

Useful Links

Get Help